66 related articles for article (PubMed ID: 8729909)
1. Efficient lipofection with cisplatin-resistant human tumor cells.
Huang L; Son K; Gao X; Hages D; Yang YY; Holden SA; Teicher B; Kirkwood J; Lazo JS
Cancer Gene Ther; 1996; 3(2):107-12. PubMed ID: 8729909
[TBL] [Abstract][Full Text] [Related]
2. Differential transactivation of human metallothionein-IIa in cisplatin-resistant and -sensitive cells.
Yang YY; Robbins PD; Lazo JS
Oncol Res; 1998; 10(2):85-98. PubMed ID: 9666516
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the drug sensitization of human tumor cells for in situ lipofection.
Son K; Huang L
Gene Ther; 1996 Jul; 3(7):630-4. PubMed ID: 8818651
[TBL] [Abstract][Full Text] [Related]
4. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
[TBL] [Abstract][Full Text] [Related]
5. Suicide gene therapy using keratin 19 enhancer and promoter in malignant mesothelioma cells.
Ishiwata N; Inase N; Fujie T; Tamaoka M; Yoshizawa Y
Anticancer Res; 2003; 23(2B):1405-9. PubMed ID: 12820402
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.
Nagatani G; Nomoto M; Takano H; Ise T; Kato K; Imamura T; Izumi H; Makishima K; Kohno K
Cancer Res; 2001 Feb; 61(4):1592-7. PubMed ID: 11245470
[TBL] [Abstract][Full Text] [Related]
7. Increased efficiency of cisplatin-resistant cell lines to DNA-mediated gene transfer with cationic liposome.
Sato T; Serikawa T; Sekine M; Aoki Y; Tanaka K
J Obstet Gynaecol Res; 2005 Oct; 31(5):368-74. PubMed ID: 16176502
[TBL] [Abstract][Full Text] [Related]
8. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism.
Riva CM
Anticancer Res; 2000; 20(6B):4463-71. PubMed ID: 11205289
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of the human interleukin-13 receptor alpha1 gene promoter.
Ise T; Izumi H; Nagatani G; Takano H; Wada M; Kuwano M; Kohno K
Biochem Biophys Res Commun; 1999 Nov; 265(2):387-94. PubMed ID: 10558877
[TBL] [Abstract][Full Text] [Related]
10. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
11. Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines.
Bonovich M; Olive M; Reed E; O'Connell B; Vinson C
Cancer Gene Ther; 2002 Jan; 9(1):62-70. PubMed ID: 11916245
[TBL] [Abstract][Full Text] [Related]
12. Development of artificial chimerical gene regulatory elements specific for cancer gene therapy.
Shin JH; Yi JK; Lee YJ; Kim AL; Park MA; Kim SH; Lee H; Kim CG
Oncol Rep; 2003; 10(6):2063-9. PubMed ID: 14534744
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
Qiu YY; Mirkin BL; Dwivedi RS
Cancer Detect Prev; 2005; 29(5):456-63. PubMed ID: 16185816
[TBL] [Abstract][Full Text] [Related]
15. Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer.
Coulson JM; Stanley J; Woll PJ
Br J Cancer; 1999 Aug; 80(12):1935-44. PubMed ID: 10471042
[TBL] [Abstract][Full Text] [Related]
16. Novel mechanisms of platinum drug resistance identified in cells selected for resistance to JM118 the active metabolite of satraplatin.
Samimi G; Kishimoto S; Manorek G; Breaux JK; Howell SB
Cancer Chemother Pharmacol; 2007 Feb; 59(3):301-12. PubMed ID: 16770583
[TBL] [Abstract][Full Text] [Related]
17. Clock and ATF4 transcription system regulates drug resistance in human cancer cell lines.
Igarashi T; Izumi H; Uchiumi T; Nishio K; Arao T; Tanabe M; Uramoto H; Sugio K; Yasumoto K; Sasaguri Y; Wang KY; Otsuji Y; Kohno K
Oncogene; 2007 Jul; 26(33):4749-60. PubMed ID: 17297441
[TBL] [Abstract][Full Text] [Related]
18. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard.
Fan S; Chang JK; Smith ML; Duba D; Fornace AJ; O'Connor PM
Oncogene; 1997 May; 14(18):2127-36. PubMed ID: 9174048
[TBL] [Abstract][Full Text] [Related]
19. Codominance of cisplatin resistance in somatic cell hybrids.
Ying YL; Shen DW; Liang XJ; Gottesman MM
J Cell Physiol; 2003 Jul; 196(1):63-9. PubMed ID: 12767041
[TBL] [Abstract][Full Text] [Related]
20. Improved in vitro gene transfer mediated by fluorinated lipoplexes in the presence of a bile salt surfactant.
Gaucheron J; Santaella C; Vierling P
J Gene Med; 2001; 3(4):338-44. PubMed ID: 11529663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
